News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
288 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38486)
2025 (20176)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (180)
2 (200)
3 (92)
4 (2)
5 (1)
6 (166)
7 (207)
8 (176)
9 (168)
10 (69)
11 (2)
12 (2)
13 (142)
14 (189)
15 (157)
16 (198)
17 (60)
18 (4)
19 (6)
20 (36)
21 (216)
22 (182)
23 (237)
24 (83)
25 (1)
26 (4)
27 (226)
28 (288)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Drug Development
FDA Grants Orphan Drug Designation to Ymmunobio’s CEACAM Antibody for the Treatment of Liver Cancer
Ymmunobio announced today that it has been granted Orphan Drug Designation (ODD) by the US Food & Drug Administration (FDA) for YB-200, a CEACAM1/5 antibody it is studying for the treatment of hepatocellular carcinoma (HCC).
February 28, 2023
·
2 min read
With a Two-Year Revenue Growth of 276%, PathogenDx Ranks No. 50 on Inc. Magazine’s List of the Southwest Region’s Fastest-Growing Private Companies
Inc. magazine revealed that PathogenDx (“PathogenDx” or “Company”), a leader in next-generation microarray technology for better health and safety, is No. 50 on its fourth annual Inc. 5000 Regionals Southwest list1
February 28, 2023
·
5 min read
BioMidwest
BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023, at 2:10 p.m. EST.
February 28, 2023
·
2 min read
Genetown
CureDuchenne Ventures Invests in hC Bioscience And its Novel tRNA-Based Therapeutic Approach for Duchenne Muscular Dystrophy
hC Bioscience, a pioneer in the development of tRNA-based therapeutics, received an investment from CureDuchenne Ventures, the strategic investment arm of CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy.
February 28, 2023
·
2 min read
Pharm Country
Hillstream BioPharma to Attend the 35th Annual ROTH Conference on March 12-14, 2023
Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”) will be attending the 35th Annual ROTH Conference, being held March 12–14 at The Ritz-Carlton Hotel in Dana Point, California.
February 28, 2023
·
4 min read
Business
Kytopen Expands Scientific Advisory Board Joined by Bioengineering Expert Mikhail Shapiro, Ph.D.
Kytopen, an MIT-spin out and biotechnology company leading advancements in high-throughput cellular and genome engineering platforms, today announced the addition of leading chemical and medical engineering expert Mikhail Shapiro, Ph.D. to the Kytopen Scientific Advisory Board (SAB).
February 28, 2023
·
2 min read
Pharm Country
Theranica’s Nerivio® Cleared by FDA for Preventive Treatment of Migraine
Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, today announced that the Nerivio® prescription wearable recently received Food and Drug Administration (FDA) clearance as a dual-use acute and preventive treatment for migraine with or without aura in people 12 years of age or older.
February 28, 2023
·
5 min read
Deals
Full Alliance Group, Inc. Announces Merger with Bio Lab Naturals, Inc. (OTCPK: FAGI)
Full Alliance Group, Inc. (OTC PINK:FAGI) operating in the health and nutraceutical space, announces it has entered into a definitive share exchange agreement with Bio Lab Naturals, Inc. (“Bio Lab”), a leading provider of innovative and high-quality health and wellness products.
February 28, 2023
·
4 min read
Previous
29 of 29